Trading Steroids for Targeted Topical Therapies: Clinical Pearls for Your AD, Psoriasis, and Seborrheic Dermatitis Patients

While corticosteroids hold a valuable place in the therapeutic toolkit for atopic dermatitis, psoriasis, seborrheic dermatitis, and similar conditions, targeted topical therapies may offer better options for individualized care. Non-steroidal targeted therapies allow for better efficacy, improved safety, long-term use, and treatment of sensitive regions of the skin. Health care professionals require expert guidance on clinical data for new and emerging targeted topical therapies and strategies for utilizing them to improve outcomes in adult and pediatric patients. This enduring, interactive monograph activity will provide learners with the most current data regarding topical therapies for common skin conditions. The activity includes expert dermatology faculty discussion of corticosteroid misuse and clinical evidence supporting the use of new and emerging non-steroidal, targeted topical therapies.

Target Audience

This activity is designed for an audience of US-based physicians, nurses and advanced practice providers (nurse practitioners and physician associates) of dermatology practice, including pediatric, adolescent, and adult dermatology.

Learning Objectives

Upon completion of the educational activity, participants should be better able to:

  • Critically analyze the clinical safety and efficacy data for current and emerging targeted topical therapies.
  • Utilize nonsteroidal treatment approaches to improve patient and disease outcomes.
Course summary
Available credit: 
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Participation
Course opens: 
05/09/2025
Course expires: 
12/02/2025
Rating: 
0
  • Phase 1: Dangers of Steroid Misuse
  • Phase 2: Non-steroidal Alternatives for Dermatologic Conditions

Christopher G. Bunick, MD, PhD
Associate Professor of Dermatology
Yale School of Medicine
New Haven, CT		Peter A. Lio, MD Vice Chair
Clinical Assistant Professor, Dermatology, Pediatrics
Northwestern University, Feinberg School of Medicine
Chicago, IL

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

0.5 ANCC contact hours.

Physician Assistants

 
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 12/2/2025. PAs should only claim credit commensurate with the extent of their participation.

Commercial Support

This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.

DISCLOSURES 

Name 

Relationship 

Commercial Interest 

Christopher G. Bunick, MD, PhD 

Advisor 

AbbVie, Apogee, LEO Pharma, Ortho Dermatologics, Sun Pharma, Novartis, Pfizer, Sanofi, Takeda, UCB 

Consultant 

 AbbVie, Almirall, Amgen, Apogee, Arcutis, Botanix, Connect BioPharma, Dermavant, Eli Lilly, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, Teladoc, UCB 

Researcher 

AbbVie, Almirall, Apogee, LEO Pharma, Ortho Dermatologics, Sun Pharma 

Peter A. Lio, MD 

Advisor 

Alphyn Biologics, AbbVie, Almirall, Amyris, Arcutis, ASLAN, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Janssen, LEO Pharma, Lipidor, L’Oreal, Merck, Micreos, MyOR Diagnostics, Pelthos Therapeutics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Sonica, Soteri Skin, Suneco Technologies, Theraplex, Thimble Health, UCB, Unilever, Verdant Scientific, Verrica, Yobee Care 

Individual stocks and stock options 

Alphyn Labs, Codex Labs, Concerto Biosci, Soteri Skin, Suneco Technologies, Thimble, Yobee Care, Verdant Scientific, All stock options only All companies either OTC only or have not made contact with FDA as of yet. 

Speaker 

AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, MyOR Diagnostics, ParentMD, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica 

Dorothy Caputo, MA, BSN, RN, President 

N/A 

Nothing to disclose 

Michele Bielarski, RN (planner/reviewer) 

N/A 

Nothing to disclose 

AKH Inc Staff and Planners 

N/A 

Nothing to disclose 

Tarsus dba LiVDerm Staff and Planners 

N/A 

Nothing to disclose 

All of the relevant financial relationships listed for these individuals have been mitigated. 

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

AKH Privacy Policy

Available Credit

  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Participation
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.